Reference is made to the annual general meeting of CellCura ASA on 27 June 2014, which resolved to reduce the company's share capital to NOK 1,304,100 through a reduction of the nominal value of the company's shares from NOK 2 to NOK 0.20. 

The capital reduction has now been registered with the Norwegian Register of Business Enterprises, and the company's share capital is now NOK 1,304,100 divided into 6,520,500 shares, each with a nominal value of NOK 0.20. The reduction amount has been partly used for coverage of loss and partly allocated to a fund to be used as decided by the general meeting. No distribution will take place in connection with the capital reduction.

Oslo, 30 October 2014

CellCura ASA

Tore Viana-Rønningen

Chief Executive Officer

Phone: + 47 911 08 693

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

distributed by